Literature DB >> 27037060

PKCε inhibits isolation and stemness of side population cells via the suppression of ABCB1 transporter and PI3K/Akt, MAPK/ERK signaling in renal cell carcinoma cell line 769P.

Bin Huang1, Shun Jun Fu2, Wen Zhe Fan3, Zhong Hua Wang4, Ze Bin Chen1, Sheng Jie Guo5, Jun Xing Chen6, Shao Peng Qiu7.   

Abstract

Protein kinase C epsilon (PKCε), a member of the novel PKC family, is known to be a transforming oncogene and tumor biomarker for many human solid cancers including renal cell carcinoma (RCC). We isolated side population (SP) cells from the RCC 769P cell line, and proved that those cells possess cancer stem cell (CSC) characteristics. In this study, to identify the function of PKCε in cancer stemness of 769P SP cells, we reduced the expression of PKCε in those cells, following the results demonstrated that PKCε depletion had a negative correlation with the existence of SP cells in 769P cell line. Down-regulation of PKCε also suppresses the CSC potential of sorted 769P SP cells in several ways: proliferation potential, resistance to chemotherapeutics and in vivo tumor formation ability. Our study also reveals that PKCε is associated with ABCB1 and this association probably contributed to the SP cells isolation from 769P cell line. Furthermore, the expression of ABCB1 is directly regulated by PKCε. Additionally, after the depletion of PKCε, the phosphorylation of pAkt, pStat3 and pERK was apparently suppressed in 769P SP cells, whereas PKCε overexpression could promote the phosphorylation of AKT, STAT3 and ERK in 769P Non-SP cells. Overall, PKCε down-regulation suppresses sorting and the cancer stem-like phenotype of RCC 769P SP cells through the regulation of ABCB1 transporter and the PI3K/Akt, Stat3 and MAPK/ERK pathways that are dependent on the phosphorylation effects. Thus, PKCε may work as an important mediator in cancer stem cell pathogenesis of renal cell cancer.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  ABCB1; Cancer stem cell; Protein kinase C epsilon; Renal cell carcinoma; Side population cells

Mesh:

Substances:

Year:  2016        PMID: 27037060     DOI: 10.1016/j.canlet.2016.03.041

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  21 in total

1.  Characteristics of Gut Microbiota in Patients With Clear Cell Renal Cell Carcinoma.

Authors:  Yang Chen; Junjie Ma; Yunze Dong; Ziyu Yang; Na Zhao; Qian Liu; Wei Zhai; Junhua Zheng
Journal:  Front Microbiol       Date:  2022-07-04       Impact factor: 6.064

2.  Enhanced expression of microtubule-associated protein 7 functioned as a contributor to cervical cancer cell migration and is predictive of adverse prognosis.

Authors:  Ning Tang; Dan Lyu; Jian-Fang Chang; Zhi-Tao Liu; Yan Zhang; Hai-Ping Liu
Journal:  Cancer Cell Int       Date:  2020-07-29       Impact factor: 5.722

3.  Cellular and physical microenvironments regulate the aggressiveness and sunitinib chemosensitivity of clear cell renal cell carcinoma.

Authors:  Kei Nagase; Takashi Akutagawa; Mihoko Rikitake-Yamamoto; Sayuri Morito; Maki Futamata; Shohei Tobu; Mitsuru Noguchi; Shuji Toda; Shigehisa Aoki
Journal:  J Pathol       Date:  2021-02-19       Impact factor: 7.996

4.  Functional significance of CD105-positive cells in papillary renal cell carcinoma.

Authors:  Damian Matak; Klaudia K Brodaczewska; Cezary Szczylik; Irena Koch; Adam Myszczyszyn; Monika Lipiec; Slawomir Lewicki; Lukasz Szymanski; Robert Zdanowski; Anna M Czarnecka
Journal:  BMC Cancer       Date:  2017-01-05       Impact factor: 4.430

5.  miR-218-5p restores sensitivity to gemcitabine through PRKCE/MDR1 axis in gallbladder cancer.

Authors:  Hui Wang; Ming Zhan; Sun-Wang Xu; Wei Chen; Man-Mei Long; Yong-Heng Shi; Qiang Liu; Man Mohan; Jian Wang
Journal:  Cell Death Dis       Date:  2017-05-11       Impact factor: 8.469

6.  Mammalian-enabled (MENA) protein enhances oncogenic potential and cancer stem cell-like phenotype in hepatocellular carcinoma cells.

Authors:  Kunpeng Hu; Pinzhu Huang; Hui Luo; Zhicheng Yao; Qingliang Wang; Zhiyong Xiong; Jizong Lin; He Huang; Shilei Xu; Peng Zhang; Bo Liu
Journal:  FEBS Open Bio       Date:  2017-06-22       Impact factor: 2.693

7.  TRIM36, a novel androgen-responsive gene, enhances anti-androgen efficacy against prostate cancer by inhibiting MAPK/ERK signaling pathways.

Authors:  Chao Liang; Shangqian Wang; Chao Qin; Meilin Bao; Gong Cheng; Bianjiang Liu; Pengfei Shao; Qiang Lv; Ninghong Song; Lixin Hua; Min Gu; Jie Li; Zengjun Wang
Journal:  Cell Death Dis       Date:  2018-02-05       Impact factor: 9.685

8.  Prostate Tumor Overexpressed-1 (PTOV1) promotes docetaxel-resistance and survival of castration resistant prostate cancer cells.

Authors:  Verónica Cánovas; Yolanda Puñal; Valentina Maggio; Enric Redondo; Mercedes Marín; Begoña Mellado; Mireia Olivan; Matilde Lleonart; Jacques Planas; Juan Morote; Rosanna Paciucci
Journal:  Oncotarget       Date:  2017-07-22

9.  MiR-486-5p negatively regulates oncogenic NEK2 in hepatocellular carcinoma.

Authors:  Shun-Jun Fu; Jian Chen; Fei Ji; Wei-Qiang Ju; Qiang Zhao; Mao-Gen Chen; Zhi-Yong Guo; Lin-Wei Wu; Yi Ma; Dong-Ping Wang; Xiao-Feng Zhu; Xiao-Shun He
Journal:  Oncotarget       Date:  2017-05-05

Review 10.  ABC Transporters in Cancer Stem Cells: Beyond Chemoresistance.

Authors:  Romana-Rea Begicevic; Marco Falasca
Journal:  Int J Mol Sci       Date:  2017-11-08       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.